Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

William Goddard

Richard Friesner

Schrödinger, Inc.

DVLP is building a new infrastructure for drug development by digitizing drug assets, financing, and development workflows to accelerate the process of turning molecules into medicines.

DVLP

Machine Translation utilizes computational biology, novel Machine Learning & AI, bioinformatic simulations, and a unique data set to determine which drug candidates will most likely succeed in clinical studies.

Machine Translation

Primordial AI utilizes evolutionary data and artificial intelligence to discover drug targets, focusing on achieving next-generation drug development.

Metric
Company Name	Schrödinger, Inc.	DVLP	Machine Translation	Primordial AI
Symbol	SDGR
MSH ID	COM:SCHRODINGER	COM:DVLPMEDICINES	COM:MACHTRANSPRO	COM:PRIMORDIALBIO
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Healthcare Information Services	Pharmaceuticals	Biotechnology	Biotechnology
Country	US	US	US	US
Stage				Seed
Employee Count	867
Website	schrodinger.com	dvlpmedicines.com	machtranspro.com	primordialbio.com
LinkedIn		dvlpmedicines		primordial-ai
Founders

Metric
Market Cap	1.50B
Enterprise Value
Monthly Web Traffic	94.03K	133	162.88K	1.24K
Web Traffic Growth	0.10	-0.55	-0.34	-0.54
Valuation
Raised Capital	10M			4M

Metric
Revenue	216.67M
Revenue (LTM)
Revenue (NTM)
Gross Profit	140.10M
EBITDA	-171.90M
Operating Income	-177.45M
Net Income	40.72M
EPS	0.57
Diluted EPS	0.54
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.66
Operating Profit Margin	-0.82
EBITDA Margin	-0.79
Net Profit Margin	0.19
Return on Equity	0.07
Return on Assets	0.05
Return on Capital Employed	-0.27

COM:SCHRODINGER

Schrödinger, Inc.

Last Close

20.37

22/11 21:00

Market Cap

1.50B

Beta: -

Volume Today

623.61K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	42.57
P/B Ratio	3.34
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	12.15
EV Multiple	-5.56

Metric
Days Sales Outstanding	58.83
Days Payables Outstanding	48.57
Days Inventory Outstanding	0.00
Operating Cycle	150.13
Cash Conversion Cycle	69.34
Asset Turnover	0.29

Metric
Operating Cash Flow	10.48M
Free Cash Flow	-2.92M
Cash Flow to Debt	-1.07
Operating Cash Flow/Sales	-0.63
Free Cash Flow Yield	-0.07

Metric
Cash & Equivalents	161.07M
Accounts Receivable	-20.03M
Inventory
Goodwill	4.79M
Debt to Capitalization	0.21
Debt to Assets	0.16
Current Ratio	5.21
Quick Ratio	4.64

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.23
R&D to Revenue	0.83
SG&A to Revenue	0.49